What is Diality?
Diality operates as a specialized medical device manufacturer dedicated to the development of versatile hemodialysis technology. The company's core mission centers on providing care providers with the tools necessary to deliver personalized treatment plans in various settings, including hospitals, nursing homes, and dialysis centers. By bridging the gap between institutional care and home-based therapy, Diality is addressing critical inefficiencies in renal care. Their platform is engineered to empower both patients and physicians, offering a scalable approach to kidney disease that emphasizes clinical flexibility and improved patient outcomes in an increasingly decentralized healthcare landscape.
How much funding has Diality raised?
Diality has raised a total of $74.8M across 4 funding rounds:
Series A
$10M
Debt
$350K
Series B
$36.5M
Other Financing Round
$28M
Series A (2019): $10M, investors not publicly disclosed
Debt (2020): $350K led by PPP
Series B (2022): $36.5M, investors not publicly disclosed
Other Financing Round (2023): $28M, investors not publicly disclosed
Key Investors in Diality
Undisclosed Investor
A private equity firm focused on long-term capital appreciation within the healthcare technology and medical device sectors.
Undisclosed Investor
A venture capital group specializing in early-to-growth stage investments in life sciences and innovative medical hardware.
Undisclosed Investor
An institutional investor with a mandate to support disruptive healthcare solutions that improve patient quality of life.
What's next for Diality?
With the recent infusion of capital, Diality is well-positioned to accelerate its product development lifecycle and expand its market footprint. The company's strategic roadmap likely involves scaling manufacturing capabilities and navigating the complex regulatory pathways required for widespread adoption of its hemodialysis systems. As the firm transitions into this next phase of growth, the focus will remain on enhancing the interoperability of its devices within existing healthcare ecosystems. By leveraging this financial momentum, Diality aims to solidify its competitive advantage, ultimately setting a new standard for personalized, accessible, and high-quality renal care on a global scale.
See full Diality company page
